Vytrus Biotech S.A. (VYT) — Free Cash Flow Generation Index

Latest as of December 2022: 3.19x

Vytrus Biotech S.A. (VYT) has a Free Cash Flow Generation Index of 3.19x as of December 2022. Free cash flow of €719.71K represents 3% of operating cash flow (€225.55K). See Vytrus Biotech S.A. short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

3.19x
Free Cash Flow / Operating CF

Free Cash Flow

€719.71K
EUR

Operating Cash Flow

€225.55K
EUR

Capital Expenditures

€494.16K
EUR

Vytrus Biotech S.A. Free Cash Flow Generation Index (2021–2025)

Historical FCF Generation Index trend for Vytrus Biotech S.A. across 5 annual periods. Explore how well can Vytrus Biotech S.A. service its debt to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Vytrus Biotech S.A. (2021–2025)

Year-by-year Free Cash Flow Generation Index for Vytrus Biotech S.A.. For the full company profile including market capitalisation, see Vytrus Biotech S.A. (VYT) total market value.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2025 0.31x €1.22 Million €3.90 Million €2.68 Million ▼ -9.8%
2024 0.35x €640.24K €1.84 Million €1.20 Million ▲ +219.9%
2023 -0.29x €-261.83K €904.39K €1.17 Million ▲ +75.7%
2022 -1.19x €-268.62K €225.55K €494.16K ▼ -402.9%
2021 0.39x €176.11K €447.92K €271.82K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).